Group One Trading’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40
Closed -$22K 7668
2022
Q3
$22K Sell
40
-1
-2% -$785 ﹤0.01% 6005
2022
Q2
$31K Buy
41
+30
+273% +$47.1K ﹤0.01% 5955
2022
Q1
$38K Buy
11
+4
+57% +$10.5K ﹤0.01% 6316
2021
Q4
$21K Sell
7
-15
-68% -$69.6K ﹤0.01% 6950
2021
Q3
$143K Sell
22
-70
-76% -$604K ﹤0.01% 5525
2021
Q2
$1.21M Buy
92
+28
+44% +$440K ﹤0.01% 3189
2021
Q1
$1.07M Buy
64
+38
+146% +$742K ﹤0.01% 3147
2020
Q4
$435K Buy
26
+21
+420% +$395K ﹤0.01% 3391
2020
Q3
$95K Sell
5
-24
-83% -$552K ﹤0.01% 4226
2020
Q2
$763K Sell
29
-7
-19% -$198K ﹤0.01% 2280
2020
Q1
$799K Buy
+36
New +$575K 0.01% 1701
2019
Q4
Sell
-5
Closed -$50K 5349
2019
Q3
$50K Buy
+5
New +$60.9K ﹤0.01% 3965
2019
Q1
Sell
-4
Closed -$49K 5073
2018
Q4
$49K Buy
+4
New +$69.3K ﹤0.01% 3574

Other funds holding KALA

Group One Trading's KALA Position: Q1 2025 in Review

Group One Trading held its KALA BIO (KALA) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7980.

Group One Trading first reported a position in KALA in Q2 2018 and has held it in 14 quarters since. The position peaked at $160K in Q4 2020. 25 funds tracked by Wall St. Rank hold KALA as of Q1 2025.

  • Group One Trading held 0 shares of KALA BIO worth $0 as of Q1 2025.
  • Group One Trading left its KALA BIO share count unchanged in Q1 2025.
  • KALA BIO made up ﹤0.01% of Group One Trading's portfolio in Q1 2025, its #7980 holding.
  • Group One Trading first reported a position in KALA BIO in Q2 2018 and has held it in 14 quarters since.
  • Group One Trading's KALA BIO position peaked at $160K in Q4 2020.
  • 25 funds tracked by Wall St. Rank held KALA BIO as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.